US20130217631A1 - Collagen mixture and method of making the same - Google Patents
Collagen mixture and method of making the same Download PDFInfo
- Publication number
- US20130217631A1 US20130217631A1 US13/848,389 US201313848389A US2013217631A1 US 20130217631 A1 US20130217631 A1 US 20130217631A1 US 201313848389 A US201313848389 A US 201313848389A US 2013217631 A1 US2013217631 A1 US 2013217631A1
- Authority
- US
- United States
- Prior art keywords
- collagen
- making
- mixture
- membrane
- avian
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000008186 Collagen Human genes 0.000 title claims abstract description 35
- 108010035532 Collagen Proteins 0.000 title claims abstract description 35
- 229920001436 collagen Polymers 0.000 title claims abstract description 35
- 239000000203 mixture Substances 0.000 title claims abstract description 19
- 238000004519 manufacturing process Methods 0.000 title description 7
- 229920002567 Chondroitin Polymers 0.000 claims description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 241000271566 Aves Species 0.000 abstract description 13
- 229940012466 egg shell membrane Drugs 0.000 abstract description 12
- 239000007788 liquid Substances 0.000 description 19
- 210000000845 cartilage Anatomy 0.000 description 10
- 239000012528 membrane Substances 0.000 description 9
- 238000000034 method Methods 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 238000010586 diagram Methods 0.000 description 4
- 210000003278 egg shell Anatomy 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- 102000000503 Collagen Type II Human genes 0.000 description 2
- 108010041390 Collagen Type II Proteins 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000011012 sanitization Methods 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01017—Lysozyme (3.2.1.17)
Definitions
- This invention is directed to creating a collagen mixture and more specifically, without limitation, creating a collagen mixture of unhydrolyzed eggshell membrane with LOS with Avian collagen.
- Such collagen is used for many things such as the healing of wounds, the production of skin creams and shampoo, the treatment of osteoarthritis and osteoporosis, and as an additive for human and pet food. While useful, the process is expensive, complicated, involving many steps, and requires harsh chemicals and inorganics which can damage unique properties. Accordingly, a method and mixture is needed in the art that addresses these deficiencies.
- An objective of the present invention is to combine Type I, V, and X collagen with Type II collagen.
- Another objective of the present invention is to provide a method of making unhydrolyzed eggshell membrane collagen with LOS that involves fewer steps and is unde-natured.
- a still further objective of the present invention is to provide a method of producing Avian collagen Type II with a greater molecular weight.
- a collagen mixture includes a portion of unhydrolyzed eggshell membrane collagen and a portion of Avian collagen.
- the method of making the eggshell membrane collagen includes separating a membrane from an eggshell, drying the membrane, and pulverizing the membrane into a powder.
- the method of making the Avian collagen includes adding an enzyme mixture to a thawed Avian cartilage to break the cartilage down into liquid form, heating the liquid cartilage to form a layer of liquid digest, raising the pH level of the liquid digest, heating the raised pH level liquid digest to form a partial solid content, and spray drying the partial solid content.
- FIG. 1 is a flow diagram of a method for making unhydrolyzed eggshell membrane collagen
- FIG. 2 is a schematic diagram of the environment for making unhydrolyzed eggshell membrane collagen
- FIG. 3 is a flow diagram for a method of making a collagen mixture
- FIG. 4 is a schematic diagram of the environment for making a collagen mixture.
- the process of making unhydrolyzed eggshell membrane collagen containing Type I, V, and X collagen and lysosyme, ovatransferin, and sialic acid (LOS) begins at step 100 by obtaining sanitized cracked eggshells 10 .
- the cracked eggshells 10 are placed on a sifter 12 at step 110 where the membrane 14 of the eggshell 10 is separated from the shell 10 .
- the sifter 12 is of any type and preferably includes a fine mesh through which the shell 10 falls while the membrane 14 is transported to the end of the sifter 12 .
- the membrane 14 is placed in a hot dryer 16 to dry the membrane and kill bacteria at step 120 . While the dryer 16 is of any type, a motion dryer is preferred to facilitate faster drying. Once dried, the membrane 14 , which is in flake form, is pulverized into a powder at step 130 . Once in powder form, the membrane is packaged preferably in a fiber drum or bag for further use and/or processing.
- the process of making the Avian collagen with LOS begins by obtaining Avian cartilage 18 , typically in frozen form at step 200 .
- the frozen cartilage 18 is thawed by placing the cartilage in a tank 20 containing hot water.
- an enzyme mixture 22 is added to the thawed cartilage 18 which breaks the cartilage down into liquid form at step 220 .
- the enzyme mixture 22 includes a liquid plant derived enzyme 24 such as papain, ficen, or bromalain; a bacterial proteolytic enzyme 26 , such as acid, neutral, or alkelian; and a buffer 28 such as acetic acid or sodium hydroxide and water for a pH buffering range of 4.8 to 6.8.
- the tank is heated to preferably 140°-160° F. such that the cartilage 18 separates into a top layer of fat 30 , a middle layer of liquid digest 32 , and a bottom layer of bone chips 34 .
- the bone chips 34 are swept away from a valve 36 in the bottom of the tank 20 and the liquid digest 32 is pumped through the valve 36 to a holding tank 38 .
- the pH level of the liquid digest 32 is raised by adding sodium hydroxide or potassium hydroxide 40 to the liquid digest 32 in the holding tank 38 .
- the pH level of the liquid digest 32 is raised to a level of 5 to 11 .
- the liquid digest 32 is pumped into an evaporator 42 where the liquid digest 32 is heated to a solid content of between 10 % to 75 % such that the liquid has a syrup consistency.
- the liquid digest is heated at a temperature of 190°-230° F. to create a solid content of 15-40%.
- the solid liquid digest 32 is transported to an area for spray drying 44 .
- the solid liquid digest is spray dried using high pressure pulse combustion.
- a carrier such as multrodextrine is added to assist in pulling off extra water from the liquid digest 32 . This results in a dry powder comprised of Avian collagen.
- the Avian collagen is mixed with the unhydrolyzed eggshell membrane collagen at step 270 to create a blended collagen mixture that includes Type I, II, III, IV, V and X collagen and LOS.
- the mixture has 70% Avian collagen to 30% eggshell membrane or alternatively 30% Avian collagen to 70% eggshell membrane collagen.
- the mixture of a portion of unhydrolyzed eggshell membrane and a portion of Avian collagen includes a minimum of 15 percent mucopolysacaride, a minimum of 5 percent chondroitin sulfite, a minimum of 2 percent hyaluronic acid, and a minimum of 20 percent protein.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Cosmetics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A collagen mixture having a portion of unhydrolyzed eggshell membrane collagen and Avian collagen.
Description
- This application is a continuation-in-part of U.S. patent application Ser. No. 13/562,680 filed Jul. 31, 2012 which is a division of U.S. patent application Ser. No. 13/197,318 filed Aug. 3, 2011 and issued as U.S. Pat. No. 8,344,106 on Jan. 1, 2013.
- This invention is directed to creating a collagen mixture and more specifically, without limitation, creating a collagen mixture of unhydrolyzed eggshell membrane with LOS with Avian collagen.
- Methods for producing collagen are known in the art. Such collagen is used for many things such as the healing of wounds, the production of skin creams and shampoo, the treatment of osteoarthritis and osteoporosis, and as an additive for human and pet food. While useful, the process is expensive, complicated, involving many steps, and requires harsh chemicals and inorganics which can damage unique properties. Accordingly, a method and mixture is needed in the art that addresses these deficiencies.
- An objective of the present invention is to combine Type I, V, and X collagen with Type II collagen.
- Another objective of the present invention is to provide a method of making unhydrolyzed eggshell membrane collagen with LOS that involves fewer steps and is unde-natured.
- A still further objective of the present invention is to provide a method of producing Avian collagen Type II with a greater molecular weight.
- These and other objectives will be apparent to one of ordinary skill in the art based upon the following written description, drawings, and claims.
- A collagen mixture includes a portion of unhydrolyzed eggshell membrane collagen and a portion of Avian collagen. The method of making the eggshell membrane collagen includes separating a membrane from an eggshell, drying the membrane, and pulverizing the membrane into a powder. The method of making the Avian collagen includes adding an enzyme mixture to a thawed Avian cartilage to break the cartilage down into liquid form, heating the liquid cartilage to form a layer of liquid digest, raising the pH level of the liquid digest, heating the raised pH level liquid digest to form a partial solid content, and spray drying the partial solid content.
-
FIG. 1 is a flow diagram of a method for making unhydrolyzed eggshell membrane collagen; -
FIG. 2 is a schematic diagram of the environment for making unhydrolyzed eggshell membrane collagen; -
FIG. 3 is a flow diagram for a method of making a collagen mixture; and -
FIG. 4 is a schematic diagram of the environment for making a collagen mixture. - Referring to the Figures, the process of making unhydrolyzed eggshell membrane collagen containing Type I, V, and X collagen and lysosyme, ovatransferin, and sialic acid (LOS) begins at
step 100 by obtaining sanitized crackedeggshells 10. The crackedeggshells 10 are placed on asifter 12 atstep 110 where the membrane 14 of theeggshell 10 is separated from theshell 10. Thesifter 12 is of any type and preferably includes a fine mesh through which theshell 10 falls while the membrane 14 is transported to the end of thesifter 12. - Once separated, the membrane 14 is placed in a
hot dryer 16 to dry the membrane and kill bacteria atstep 120. While thedryer 16 is of any type, a motion dryer is preferred to facilitate faster drying. Once dried, the membrane 14, which is in flake form, is pulverized into a powder atstep 130. Once in powder form, the membrane is packaged preferably in a fiber drum or bag for further use and/or processing. - The process of making the Avian collagen with LOS begins by obtaining
Avian cartilage 18, typically in frozen form atstep 200. At step 210, the frozencartilage 18 is thawed by placing the cartilage in atank 20 containing hot water. Once thawed, anenzyme mixture 22 is added to thethawed cartilage 18 which breaks the cartilage down into liquid form atstep 220. Preferably, theenzyme mixture 22 includes a liquid plant derivedenzyme 24 such as papain, ficen, or bromalain; a bacterialproteolytic enzyme 26, such as acid, neutral, or alkelian; and abuffer 28 such as acetic acid or sodium hydroxide and water for a pH buffering range of 4.8 to 6.8. As theenzyme mixture 22 breaks down thecartilage 18, the tank is heated to preferably 140°-160° F. such that thecartilage 18 separates into a top layer offat 30, a middle layer ofliquid digest 32, and a bottom layer ofbone chips 34. - Once separated, at step 230, the
bone chips 34 are swept away from avalve 36 in the bottom of thetank 20 and theliquid digest 32 is pumped through thevalve 36 to aholding tank 38. Once pumped, atstep 240, the pH level of theliquid digest 32 is raised by adding sodium hydroxide orpotassium hydroxide 40 to theliquid digest 32 in theholding tank 38. Preferably the pH level of theliquid digest 32 is raised to a level of 5 to 11. - At
step 250, after the pH level is raised, theliquid digest 32 is pumped into anevaporator 42 where theliquid digest 32 is heated to a solid content of between 10% to 75% such that the liquid has a syrup consistency. Preferably the liquid digest is heated at a temperature of 190°-230° F. to create a solid content of 15-40%. - Next, at
step 260, thesolid liquid digest 32 is transported to an area for spray drying 44. Preferably, the solid liquid digest is spray dried using high pressure pulse combustion. Also, a carrier such as multrodextrine is added to assist in pulling off extra water from theliquid digest 32. This results in a dry powder comprised of Avian collagen. - Once the Avian collagen has been spray dried it is mixed with the unhydrolyzed eggshell membrane collagen at
step 270 to create a blended collagen mixture that includes Type I, II, III, IV, V and X collagen and LOS. Preferably the mixture has 70% Avian collagen to 30% eggshell membrane or alternatively 30% Avian collagen to 70% eggshell membrane collagen. Once combined, at step 280, the mixture is packaged and distributed. - Preferably, the mixture of a portion of unhydrolyzed eggshell membrane and a portion of Avian collagen includes a minimum of 15 percent mucopolysacaride, a minimum of 5 percent chondroitin sulfite, a minimum of 2 percent hyaluronic acid, and a minimum of 20 percent protein. The following is a test result on the collagen mixture:
-
Analyte Result chondroitin sulfate 24.60% wt hyaluronic acid 11.96% wt mucopolysacaride 43.72% wt - Accordingly, a collagen mixture and method of making the same has been disclosed that, at the very least, meets all the stated objectives.
Claims (1)
1. A collagen mixture, comprising:
a minimum of 15 percent mucopolysacaride;
a minimum of 5 percent chondroitin sulfite,
a minimum of 2 percent hydaluronic acid; and
a mimimum of 20 percent protein.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/848,389 US20130217631A1 (en) | 2011-08-03 | 2013-03-21 | Collagen mixture and method of making the same |
US14/641,973 US9149512B2 (en) | 2011-08-03 | 2015-03-09 | Collagen mixture and method of making the same |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/197,318 US8344106B1 (en) | 2011-08-03 | 2011-08-03 | Collagen mixture and method of making the same |
US13/562,680 US20130035474A1 (en) | 2011-08-03 | 2012-07-31 | Collagen mixture and method of making the same |
US13/848,389 US20130217631A1 (en) | 2011-08-03 | 2013-03-21 | Collagen mixture and method of making the same |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/562,680 Continuation-In-Part US20130035474A1 (en) | 2011-08-03 | 2012-07-31 | Collagen mixture and method of making the same |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/641,973 Continuation US9149512B2 (en) | 2011-08-03 | 2015-03-09 | Collagen mixture and method of making the same |
Publications (1)
Publication Number | Publication Date |
---|---|
US20130217631A1 true US20130217631A1 (en) | 2013-08-22 |
Family
ID=48982726
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/848,389 Abandoned US20130217631A1 (en) | 2011-08-03 | 2013-03-21 | Collagen mixture and method of making the same |
US14/641,973 Active US9149512B2 (en) | 2011-08-03 | 2015-03-09 | Collagen mixture and method of making the same |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/641,973 Active US9149512B2 (en) | 2011-08-03 | 2015-03-09 | Collagen mixture and method of making the same |
Country Status (1)
Country | Link |
---|---|
US (2) | US20130217631A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9370778B2 (en) | 2013-05-21 | 2016-06-21 | K & S Investments, L.P. | Eggshell membrane separation process |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017147796A1 (en) * | 2016-03-02 | 2017-09-08 | 世界家庭用具制品厂有限公司 | Eggshell recycling method and a use thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6780841B2 (en) * | 2001-11-13 | 2004-08-24 | Biocell Technology, Llc | Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6025327A (en) * | 1997-08-08 | 2000-02-15 | Biocell Technology, Llc | Hydrolyzed collagen type II and use thereof |
US20080063677A1 (en) * | 2004-03-10 | 2008-03-13 | New Life Resources, Llc | Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations |
-
2013
- 2013-03-21 US US13/848,389 patent/US20130217631A1/en not_active Abandoned
-
2015
- 2015-03-09 US US14/641,973 patent/US9149512B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6780841B2 (en) * | 2001-11-13 | 2004-08-24 | Biocell Technology, Llc | Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same |
Non-Patent Citations (1)
Title |
---|
VitaBase product information Kolla2 < http://www.vitabase.com/supplements/joint-bone-health/arthritis-joint-pain/neocell-immucell-wkolla2-collagen-ii.aspx > Retrieved 05/27/2014 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9370778B2 (en) | 2013-05-21 | 2016-06-21 | K & S Investments, L.P. | Eggshell membrane separation process |
Also Published As
Publication number | Publication date |
---|---|
US20150182598A1 (en) | 2015-07-02 |
US9149512B2 (en) | 2015-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8344106B1 (en) | Collagen mixture and method of making the same | |
CN109170469A (en) | A kind of Isin glue collagen peptide solid beverage and preparation method thereof | |
CN106701879A (en) | Method for extracting type I collagen | |
US20130137854A1 (en) | Collagen mixture and method of making the same | |
CN106244657A (en) | A kind of squid antioxidation polypeptide and its preparation method and application | |
CN106260494A (en) | A kind of processing method of feather albumen powder | |
CN106722368A (en) | A kind of preparation method of Salted duck egg | |
US9149512B2 (en) | Collagen mixture and method of making the same | |
CN103114117A (en) | Method for preparing fish egg sugar protein with anti-osteoporosis effect | |
CN103815437B (en) | Cultured large yellow croaker superhigh pressure degreasing preservation method | |
CN106616541A (en) | Preparation method of sea cucumber extract | |
US20130079496A1 (en) | Collagen mixture and method of making the same | |
RU2011132422A (en) | METHOD FOR PRODUCING DRY PRODUCT FROM BROWN SEA ALGAE AND FOOD PRODUCT ON ITS BASIS (OPTIONS) | |
CN102370111A (en) | Cucumaria japonica tenderizer and its tenderization method | |
JP2007054024A (en) | Improver for dried meat and dried fish, and method for producing dried meat and dried fish using the same | |
CN104910815A (en) | Method for extracting gelatin from rabbit skin | |
CN113122604B (en) | Sea intestine glue and preparation method and application thereof | |
US20150203569A1 (en) | Method of making collagen powder from marine cartilage and skin | |
CN104365832A (en) | Biological curing and preservation method of green plums | |
CN105002246A (en) | Fish polypeptide with uniform molecular weight distribution, and preparation method thereof | |
CN103141838A (en) | Preparation method and application of female calcium supplementing product | |
CN105200107B (en) | The extracting method of Onchidium struma muscle crude protein | |
CN107557419A (en) | A kind of preparation method of low value fish-bone polypeptide chelate calcium | |
CN112998185A (en) | Complex enzyme preparation assisting in molecular diffusion, food pickling method and pickled product | |
JP5220896B2 (en) | Manufacturing processed foods using soy sauce |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: MOLECULAR BIOLOGY INTERNATIONAL, INC., IOWA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HOED, ROBERT DEN;REEL/FRAME:030060/0769 Effective date: 20130318 |
|
STCB | Information on status: application discontinuation |
Free format text: EXPRESSLY ABANDONED -- DURING EXAMINATION |